TRIMBOW

उत्पाद अवलोकन

About TRIMBOW

TRIMBOW is a prescription inhalation medication designed to manage chronic obstructive airway conditions. It combines a potent anti‑inflammatory corticosteroid, a long‑acting bronchodilator, and a mucolytic agent to provide comprehensive respiratory support. The formulation delivers dipropionate de beclometasone to reduce airway inflammation, formoterol fumarate to relax bronchial smooth muscle, and bromide glicopirronio to thin mucus and improve airflow. The drug is intended for use in patients with asthma or chronic obstructive pulmonary disease who require regular maintenance therapy. It is administered via a metered‑dose inhaler, ensuring precise dosing and direct delivery to the lungs. The medication is part of a broader therapeutic strategy that may include rescue inhalers and other supportive treatments. Patients should follow the prescribed inhalation technique and adhere to the dosing schedule to achieve optimal control of symptoms.

Key Benefits & Uses

• Reduces airway inflammation through a corticosteroid component.
• Provides sustained bronchodilation with a long‑acting beta‑agonist.
• Improves mucus clearance with a mucolytic agent.

Active Ingredient & Action

The active ingredients in TRIMBOW are dipropionate de beclometasone, formoterol fumarate, and bromide glicopirronio. Dipropionate de beclometasone suppresses inflammatory mediators in the airways, formoterol fumarate stimulates beta‑2 adrenergic receptors to relax bronchial smooth muscle, and bromide glicopirronio breaks down mucus viscosity, facilitating easier exhalation. Together, these components address the primary pathophysiological mechanisms of obstructive airway disease.

Important Notes

TRIMBOW is a prescription medication and should be used only under the supervision of a qualified healthcare professional. Patients should be advised to rinse their mouth after inhalation to reduce the risk of oral candidiasis. The medication is not intended for acute relief of severe bronchospasm; a rescue inhaler should be used in such situations. Patients with a history of hypersensitivity to any component should avoid this product. Regular follow‑up appointments are recommended to monitor lung function and adjust therapy as needed.